Montefiore Medical Center PRIME
Welcome,         Profile    Billing    Logout  
 11 Trials 
20 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Thompson, John
NCT05307341: Improving Pain Management and Decreasing LOS After Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA)

Recruiting
4
100
US
sufentanil, sufentanil (DSUVIA)
More Foundation
Pain
06/23
06/23
NCT05893537: Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Recruiting
2
246
US
Active Comparator CT1812, Placebo Comparator
Cognition Therapeutics
Age-Related Macular Degeneration
07/27
08/27
PYNNACLE, NCT04585750: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

Recruiting
1/2
230
Europe, US, RoW
PC14586, rezatapopt, pembrolizumab, KEYTRUDA®, MK-3475, KEYNOTE-D79, MK-3475-D79
PMV Pharmaceuticals, Inc, Merck Sharp & Dohme LLC
Advanced Solid Tumor, Advanced Malignant Neoplasm, Metastatic Cancer, Metastatic Solid Tumor, Lung Cancer, Ovarian Cancer, Endometrial Cancer, Prostate Cancer, Colorectal Cancer, Breast Cancer, Other Cancer, Locally Advanced, Head and Neck Cancer
03/26
07/26
NCT03377569: Subcortical Oscillations in Human Sleep Dysregulation

Active, not recruiting
N/A
15
US
Sleep, PD and DBS
University of Colorado, Denver
Parkinson Disease, REM Behavior Disorder
08/20
12/24
NCT04620551: Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease

Active, not recruiting
N/A
20
US
Sub-clinical stimulation
University of Nebraska, Stanford University, University of Colorado, Denver, University of Pennsylvania
Parkinson Disease, Sleep Fragmentation
06/24
06/24
Goel, Sanjay
NCT04137107: Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Recruiting
2/3
348
US, RoW
Oxaliplatin, Duloxetine Hydrochloride, Duloxetine, Quality-of-Life Assessment, Questionnaire Administration, Placebo
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8
02/25
12/25
NCT04393454: Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy

Terminated
2
6
US
Sirolimus 2Mg Tab
Albert Einstein College of Medicine
Metastatic dMMR Solid Cancer, Solid Tumor, Cancer, Metastatic Solid Tumor
05/23
05/23
NCT05221320: Trial of Ulixertinib in Combination With Hydroxychloroquine in Patients With Advanced Gastrointestinal (GI) Malignancies

Recruiting
2
215
US
Ulixertinib, BVD-523, BVD523, Hydroxychloroquine
BioMed Valley Discoveries, Inc
Tumor, Solid, Gastrointestinal Cancer
12/24
03/25
KEYNOTE F92, NCT05597839: Study of DF9001 in Patients With Advanced Solid Tumors

Recruiting
1/2
242
US
DF9001, pembrolizumab, KEYTRUDA®
Dragonfly Therapeutics, Merck Sharp & Dohme LLC
Solid Tumor, Adult
08/25
11/27
NCT04565275: A Study of ICP-192 in Patients With Advanced Solid Tumors

Recruiting
1/2
45
US, RoW
Drug ICP-192
Beijing InnoCare Pharma Tech Co., Ltd.
Advanced Solid Tumors, Urothelial Carcinoma, Cholangiocarcinoma
11/23
04/24
XTX202-01, NCT05052268: XTX202 in Patients With Advanced Solid Tumors

Active, not recruiting
1/2
189
US
XTX202
Xilio Development, Inc.
Advanced Solid Tumor
02/26
02/26
DF1001-001, NCT04143711: Study of DF1001 in Patients With Advanced Solid Tumors

Recruiting
1/2
378
Europe, US
DF1001, Nivolumab, Nab paclitaxel, Sacituzumab Govitecan-hziy
Dragonfly Therapeutics
Solid Tumor, Adult
10/26
12/26
NCT04381650 / 2020-004325-23: A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Active, not recruiting
1/2
49
Europe, Japan, US, RoW
TAK-981, Pembrolizumab
Takeda, Takeda Development Center Americas, Inc.
Advanced or Metastatic Solid Tumors
11/25
11/25
FIH, NCT04104776 / 2020-004952-14: A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas

Recruiting
1/2
210
Europe, US, RoW
CPI-0209
Constellation Pharmaceuticals
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant, Prostatic Neoplasms, Castration-Resistant, Endometrial Cancer, Ovarian Clear Cell Carcinoma
12/25
03/26
NCT06028074: Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

Recruiting
1/2
111
US
GIM122, GIM-122
Georgiamune Inc
Advanced Solid Malignancies
09/26
12/26
NCT06322693: A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)

Recruiting
1
475
Europe, US, RoW
TSR-022, Nivolumab, TSR-042, TSR-033, Docetaxel, Pemetrexed, Cisplatin, Carboplatin
GlaxoSmithKline
Neoplasms
08/25
02/27
NCT04412616: ZZ06 in Adult Patients With Advanced EGFR Positive Solid Tumor Malignancies

Recruiting
1
60
US, RoW
ZZ06
Changchun Intellicrown Pharmaceutical Co. LTD, Covance
Advanced EGFR Positive Solid Tumor
12/23
04/24
NCT04446260: A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors

Recruiting
1
226
US, RoW
SHR-A1811
Jiangsu HengRui Medicine Co., Ltd., Atridia Pty Ltd.
Advanced Solid Tumors
12/23
12/23
AMBER, NCT02817633: A Study of TSR-022 in Participants With Advanced Solid Tumors

Hourglass Oct 2019 - Mar 2020 : From AMBER trial
Checkmark From AMBER trial at SITC 2018 [screenshot]
Nov 2018 - Nov 2018: From AMBER trial at SITC 2018 [screenshot]
Checkmark From AMBER trial in combination with TSR-022 at SITC 2018
Nov 2018 - Nov 2018: From AMBER trial in combination with TSR-022 at SITC 2018
Recruiting
1
447
Europe, US, RoW
TSR-022, Nivolumab, TSR-042, TSR-033, Docetaxel, Pemetrexed, Cisplatin, Carboplatin
Tesaro, Inc.
Neoplasms
04/25
04/27
NCT05831995: Safety and Effectiveness of ABM-168 in Adults With Advanced Solid Tumors.

Recruiting
1
112
US
ABM-168
ABM Therapeutics Corporation
Advanced Solid Tumor, RAS Mutation, RAF Mutation, NF1 Mutation
10/25
10/25
Peloso, Camille
No trials found

Download Options